Diversus Health Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 100 West Bennett Ave, Cripple Creek, CO 80813 Phone: 719-572-6100 |
Bright Futures Psychiatry Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 100 W Bennett Ave, Cripple Creek, CO 80813 Phone: 719-289-3173 Fax: 866-718-1677 |
Pickett Psychological Services, Llc Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 100 W. Bennett Avenue, Cripple Creek, CO 80813 Phone: 719-598-3585 |
Diversus Health Services Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 100 W Bennett Ave, Cripple Creek, CO 80813 Phone: 719-572-6100 |
News Archive
Applied BioCode, Inc. announced that its BioCode-1000 Analyzer has been CE Certified under the compliance of Laboratory Equipment Standards EN55011, EN61010-1, EN61326-1, IEC61010, EN61000-3-2, and EN61000-3-3. The CE Certified marking that the BioCode-1000 Analyzer has met all relevant European Union consumer safety requirements.
All over the world, patients with chronic pain struggle to express how they feel to the doctors and health-care providers who are trying to understand and treat them. Now, a University at Buffalo psychiatrist is attempting to help patients suffering from chronic pain and their doctors by drawing on ontology, the branch of philosophy concerned with the nature of being or existence.
The Children's Hospital of Philadelphia announces the availability of proton therapy, a precise form of cancer radiation that offers potentially life-changing benefits to children with brain tumors and other solid tumors. The Hospital's Cancer Center has recently begun using proton treatment at the new Roberts Proton Therapy Center, a cutting-edge radiation oncology facility located across the street from Children's Hospital in Penn Medicine's Perelman Center for Advanced Medicine.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the U.S. and Europe, a drug that resolves tophi in less than one year would become the patient share leader in the chronic tophaceous gout patient subpopulation and would be used in the vast majority of patients who suffer severe tophaceous gout, according to surveyed U.S. and European rheumatologists.
In-hospital mortality for ICU patients is often used as a quality measure, but discharge practices may bias results in a way that disadvantages large academic hospitals, according to a recently conducted study.
› Verified 8 days ago